Zobrazeno 1 - 10
of 105
pro vyhledávání: '"Consuelo BUTTIGLIERO"'
Autor:
Giovanni Farinea, Mariangela Calabrese, Federica Carfì, Isabella Saporita, Stefano Poletto, Marco Donatello Delcuratolo, Fabio Turco, Marco Audisio, Francesco Rosario Di Stefano, Marcello Tucci, Consuelo Buttigliero
Publikováno v:
Cells, Vol 13, Iss 16, p 1396 (2024)
Neuroendocrine differentiation (NED) represents a possible androgen receptor pathway inhibitors (ARPI) resistance mechanism in metastatic castration resistance prostate cancer (mCRPC). As mCRPC with NED has been excluded from clinical trials evaluati
Externí odkaz:
https://doaj.org/article/decb279708334df5b7371aef726bf931
Autor:
Francesco Fiorica, Consuelo Buttigliero, Daniela Grigolato, Marco Muraro, Fabio Turco, Fernando Munoz, Marcello Tucci
Publikováno v:
Current Oncology, Vol 29, Iss 12, Pp 9511-9524 (2022)
In recent years, significant changes have occurred in metastatic hormone-sensitive prostate cancer (mHSPC) management, where docetaxel and new androgen receptor pathway inhibitors (ARPI) have been shown to improve overall survival (OS) compared to an
Externí odkaz:
https://doaj.org/article/58f3749ac387463c8d73e63d03162dfd
Autor:
Fabio Turco, Marcello Tucci, Marco Donatello Delcuratolo, Rosario Francesco Di Stefano, Chiara Pisano, Alessandro Audisio, Marco Audisio, Antonio Ungaro, Cinzia Ortega, Massimo Di Maio, Giorgio Vittorio Scagliotti, Consuelo Buttigliero
Publikováno v:
Cancer Communications, Vol 42, Iss 8, Pp 683-688 (2022)
Externí odkaz:
https://doaj.org/article/d06654afbb024f619266ea998729db80
Autor:
Alessandro Samuelly, Marco Audisio, Cristina Cecchi, Simona Carnio, Maria Vittoria Pacchiana, Consuelo Buttigliero
Publikováno v:
Journal of Cancer Rehabilitation, Vol 4, Iss 1, Pp 233-241 (2021)
Cancer’s impact on sexuality has been well documented across all types of cancers, both in patients with active cancers and long-term survivors. As we make progresses in extending survival for cancer patients, we must face the challenge of providin
Externí odkaz:
https://doaj.org/article/10ad2a3c367540028372d6aeb4865bf2
Autor:
Marco Audisio, Consuelo Buttigliero, Fabio Turco, Marco Donatello Delcuratolo, Chiara Pisano, Elena Parlagreco, Rosario Francesco Di Stefano, Lavinia Di Prima, Veronica Crespi, Giovanni Farinea, Massimiliano Cani, Marcello Tucci
Publikováno v:
Cells, Vol 11, Iss 10, p 1614 (2022)
Urothelial cancer is a lethal malignancy characterized by a wide diffusion in Western countries due to a larger exposure to known risk factors, such as aromatic amines, tobacco smoke and benzene [...]
Externí odkaz:
https://doaj.org/article/12d9efc0cf6a48a38ae1daa47ecc4784
Autor:
Antonio Ungaro, Marcello Tucci, Alessandro Audisio, Lavinia Di Prima, Chiara Pisano, Fabio Turco, Marco Donatello Delcuratolo, Massimo Di Maio, Giorgio Vittorio Scagliotti, Consuelo Buttigliero
Publikováno v:
Cells, Vol 11, Iss 5, p 803 (2022)
Significant progress has been achieved over the last decades in understanding the biology and mechanisms of tumor progression in urothelial carcinoma (UC). Although the therapeutic landscape has dramatically changed in recent years with the introduct
Externí odkaz:
https://doaj.org/article/762d63be19414b60a3abceb3859189e3
Autor:
Alessandro Audisio, Consuelo Buttigliero, Marco Donatello Delcuratolo, Elena Parlagreco, Marco Audisio, Antonio Ungaro, Rosario Francesco Di Stefano, Lavinia Di Prima, Fabio Turco, Marcello Tucci
Publikováno v:
Cells, Vol 11, Iss 3, p 357 (2022)
Non-muscle-invasive bladder cancer (NMIBC) is characterized by a high rate of cure, but also by a non-negligible probability of recurrence and risk progression to muscle-invasive disease. NMIBC management requires a proper local resection and staging
Externí odkaz:
https://doaj.org/article/6e7a10f94ebb48bd91d7f07029d690b5
Autor:
Fabio Turco, Marcello Tucci, Tiziana Angusti, Antonella Parente, Rosario Francesco Di Stefano, Susanna Urban, Chiara Pisano, Alessandro Samuelly, Alessandro Audisio, Marco Audisio, Elena Parlagreco, Antonio Ungaro, Giorgio Vittorio Scagliotti, Massimo Di Maio, Consuelo Buttigliero
Publikováno v:
Tumori Journal. 109:233-243
Background: Radium 223 (Ra-223) was approved for the treatment of metastatic castration resistant prostate cancer (mCRPC) patients with bone-only disease, following demonstration of significant improvement in overall survival (OS). To date, there are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e419105ba52787f998d7dabf03d536b
https://doi.org/10.1177/03008916221077144
https://doi.org/10.1177/03008916221077144
Autor:
Silke Gillessen, Giuseppe Procopio, Stefanie Hayoz, Eloïse Kremer, Michael Schwitter, Orazio Caffo, David Lorente, Augusto Pedrazzini, Guilhem Roubaud, Soazig Nenan, Aurelius Omlin, Consuelo Buttigliero, Juan Ignacio Delgado Mingorance, Aránzazu González-del-Alba, Maria Teresa Delgado, Franco Nole, Fabio Turco, Ricardo Pereira Mestre, Karin Ribi, Richard Cathomas
PURPOSE To assess the efficacy and safety of darolutamide maintenance after successful taxane chemotherapy in patients with metastatic castration-resistant prostate cancer (mCRPC). PATIENTS AND METHODS Swiss Group for Clinical Cancer Research (SAKK)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e16645cea5d57dacafafbc6aaa75ac7
https://hdl.handle.net/2318/1893660
https://hdl.handle.net/2318/1893660
Autor:
Fabio Turco, Lavinia Di Prima, Chiara Pisano, Stefano Poletto, Marco De Filippis, Veronica Crespi, Giovanni Farinea, Massimiliano Cani, Mariangela Calabrese, Isabella Saporita, Rosario Francesco Di Stefano, Marcello Tucci, Consuelo Buttigliero
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50e98cf9daef6942afb2c2eb4d9276de
https://hdl.handle.net/2318/1893658
https://hdl.handle.net/2318/1893658